Electronic prescribing (e-prescribing), which is intended to ensure that accurate, error-free and understandable prescriptions are sent directly to pharmacies, was found to lower the risks among diabetes patients of experiencing adverse drug events that required emergency department visits or hospitalizations. In an AHRQ-supported article, researchers examined 2011–2013 data for 3.1 million Medicare Part D beneficiaries who were 66 or older and had taken antidiabetes medications for at least 90 days. Their analysis, published in Medical Care, showed 21 adverse drug events per 1,000 beneficiaries who had at least 75 percent of their medications e-prescribed. Beneficiaries with less e-prescribing, meanwhile, had more adverse drug events—with the highest rate, 44 events per 1,000 diabetes patients, occurring for those patients who had 0.1 percent to 24.9 percent of their prescriptions handled electronically. Access the abstract.E-Prescribing and Adverse Drug Events: An Observational Study of the Medicare Part D Population With Diabetes. - PubMed - NCBI
Med Care. 2017 Jan 3. doi: 10.1097/MLR.0000000000000684. [Epub ahead of print]
E-Prescribing and Adverse Drug Events: An Observational Study of the Medicare Part D Population With Diabetes.